Jessica G. C. A. M. Buijs-Gladdines

Author

Also Known As

J Buijs-Gladdines, J G C A M Buijs-Gladdines, J. Buijs-Gladdines, J. G. C. A. M. Buijs-Gladdines, Jessica Buijs-Gladdines, Jessica G. Buijs-Gladdines, Jessica G. C. A. M. Buijs-Gladdines, Jessica G. C. Buijs‐Gladdines, Jessica G.C.A.M. Buijs-Gladdines, Jessica G.C.A.M. Buijs-gladdines

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC - Sophia Children’s Hospital Stichting Kinderoncologie Nederland Princess Máxima Center Universität Hamburg

About

Jessica G. C. A. M. Buijs-Gladdines is an author at Erasmus MC specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	827
2	Immunology	5	5	793
3	Pathology	4	4	403
4	Cell Biology	3	3	511
5	Health Sciences	1	1	34

Jessica G. C. A. M. Buijs-Gladdines

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia Irene Homminga, Rob Pieters, Anton W. Langerak, Cancer Cell Hematological MalignancyMixed-phenotype Acute LeukemiaImmunologyPotential OncogenesAdult T-cell Leukemia-lymphoma	2011	378
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, Blood	2008	222
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia Pieter Van Vlierberghe, Martine van Grotel, H. Berna Beverloo, Blood	2006	165
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences Martine van Grotel, Jules P.P. Meijerink, Elisabeth R. van Wering, Leukemia Pediatric T-allAutoimmune DiseaseGenetic DisorderImmunodeficienciesMolecular-cytogenetic Abnormalities	2007	142
NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols Linda Zuurbier, Irene Homminga, Valerie Calvert, Leukemia Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaImmunology	2010	140
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia Linda Zuurbier, Emanuel F. Petricoin, Maartje Vuerhard, Haematologica	2012	124
IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study Yunlei Li, Jessica G. C. A. M. Buijs-Gladdines, Kirsten Canté-Barrett, PLoS Medicine	2016	102
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia Diana Schotte, Ellen Lange-Turenhout, Dominique J. P. M. Stumpel, Haematologica	2010	93
MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia Kirsten Canté-Barrett, J A P Spijkers-Hagelstein, Jessica G. C. A. M. Buijs-Gladdines, Leukemia	2016	89
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors Linda Zuurbier, Alejandro Gutiérrez, Charles G. Mullighan, Haematologica Hematological MalignancyImmature ClusterImmature Cluster CasesMedicineMixed-phenotype Acute Leukemia	2013	87

Page 1